Compounded GLP-1 medications at a fraction of branded costs Licensed U.S
this increases GLP-1 as well
Compounding Pharmacies Market Size to Hit USD 10.93 Billion by 2034, accessed December 19, 2025, Breaking Down Patent Barriers: A Guide for Compounding Pharmacies DrugPatentWatch, accessed December 19, 2025, Compounding when Drugs are on FDAs Drug Shortages List, accessed December 19, 2025, Compounding Inequities Through Drug IP and Unfair Competition by Shweta Kumar Scholarship @ GEORGETOWN LAW, accessed December 19, 2025, Compounding Problems: Recent Decisions on Tirzepatide Highlight Interplay Between FDA Anti-Compounding Enforcement and Private Intellectual Property Rights | Axinn, Veltrop & Harkrider LLP, accessed December 19, 2025, Tirzepatide Ruling: Implications for Compounders in an Evolving Legal Landscape, accessed December 19, 2025, Intellectual Property Challenges for 503A Pharmacy Compounding Frier Levitt, accessed December 19, 2025, Evaluating Risk When Prescribing Compounded Semaglutide MICA, accessed December 19, 2025, An Update on the Status of Semaglutide Compounding CAHABA HEALTH, accessed December 19, 2025, PAR Pharmaceutical Inc v
Injections arent going anywhere, but the era of pop a pill, not a pen has officially begun
